The continuous delivery of agomiR‐130b led to a greater tumour weight, whereas the continuous delivery of the SASH1 overexpression plasmids yielded a reduced tumour weight (P < 0.01, Figure 7C). This evidence concerns the gene SASH1 and neoplasm.